ClinicalTrials.gg
Not yet recruitingNCT06857513PICUS2Updated Sep 8, 2025

Post-ICU Syndrome Over Time in Patients With Respiratory Failure

An observational study in Post-Intensive Care Syndrome and Quality of Life, sponsored by Hospital Universitario de Gran Canaria Doctor Negrín. Not yet recruiting at 1 site in Spain. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2025-09-08.

Sponsored by Hospital Universitario de Gran Canaria Doctor Negrín · Observational

How we know

From the registry’s dates

  • Primary completion was expected by Dec 2025, 10 months ago, but the record still lists the study as not yet recruiting.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Cohort
Time perspective
Cross-sectional
Enrollment
90
Ages
18 Years and older
Sex
All
01

Study summary

Intensive Care Units (ICU) stabilize and maintain vital functions in critically ill patients, optimizing their survival. However, patients with prolonged stays may develop Post-ICU syndrome , characterized by physical, cognitive and psychological dysfunctions. This syndrome considerably affects the quality of life of patients. The risk of post-ICU syndrome is associated with factors such as advanced age, delirium, prolonged sedation and mechanical ventilation.

The main objective of this study is to assess the temporal evolution of post-ICU syndrome in patients who required mechanical ventilation for more than 48 hours, analyzing its incidence, associated risk factors and the impact on their long-term quality of life.

This cross-sectional study evaluates the presence of post-ICU syndrome in 2025 in patients who have been admitted to the ICU during 2021 and 2024 who required invasive mechanical ventilation for more than 48 hours. Of this total, deceased persons, those who did not give their consent, and minors will not be included.

Read the detailed description

Advances in intensive care have improved short-term survival rates, but survivors of prolonged ICU stays may face medium- and long-term morbidities, influenced by both the critical illness and the ICU environment. This highlights the importance of a comprehensive approach to their care, focused on improving post-ICU quality of life.

Post-intensive care syndrome is defined as the appearance or worsening of physical, cognitive and/or mental health impairments in patients who survive a stay in an ICU. This syndrome usually manifests during the first 48 hours after admission or after discharge, persisting in the long term and negatively affecting quality of life and daily functionality. In the physical field, is characterized by acquired neuromuscular weakness that frequently limits the patient's autonomy. Regarding psychological dysfunction, disorders such as anxiety, depression and post-traumatic stress disorder are observed; in the neurocognitive field, dysfunctions in memory, attention and executive functions affect daily life. This syndrome considerably affects the quality of life of patients. The risk of post-ICU syndrome is associated with factors such as advanced age, delirium, prolonged sedation and mechanical ventilation.

The main objective of this study is to assess the temporal evolution of post-ICU syndrome in patients who required mechanical ventilation for more than 48 hours.

Specific objectives:

  • To establish the incidence of PICUS in patients admitted to the ICU for respiratory failure between January 2021 and December 2024.
  • To identify the risk factors associated with the development of post-ICU syndrome in these patients, considering both clinical and sociodemographic factors.
  • To evaluate the impact of post-ICU syndrome on the quality of life of patients over time, studying the physical, cognitive and psychological consequences of the syndrome.
  • To explore the impact on their families, analyzing the emotional impact and the quality of life of caregivers.

This is a cross-sectional study, in which no experimental intervention will be carried out on the patients.

The study population will be patients hospitalized in the Intensive Care Unit between January 2021 and December 2024 undergoing mechanical ventilation for more than 48 hours. Deceased persons, those who did not give their consent, and minors will not be included. The final sample size is expected to be representative for the purposes of the study.

Data collection will be carried out through interviews in 2025, which will allow obtaining detailed information on the current situation of these patients about the presence of symptoms as a consequence of their stay in the ICU more than two years ago.

02

Conditions studied

  • Post-Intensive Care Syndrome
  • Quality of Life

Keywords

  • risk factors
  • intensive care unit
  • comorbidities
03

In context

postintensive care syndrome

106 studies on the registry are indexed under postintensive care syndrome; 49 are open to participants now.

This study's planned enrollment of 90 is below the median of 135 across 56 observational studies indexed under postintensive care syndrome.

Browse postintensive care syndrome studies →

Lead sponsor

Hospital Universitario de Gran Canaria Doctor Negrín is the lead sponsor of 11 studies on the registry; 7 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Patients hospitalized in the ICU between January 2021 and December 2023 undergoing mechanical ventilation for more than 48 hours

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Patients admitted to the ICU between January 2021 and December 2023 who have required invasive mechanical ventilation for a period of more than 48 hours.
  • Patients who give their to participate in the study.
  • Patients aged 18 years or older

Exclusion criteria

Exclusion Criteria:

  • Patients who have been subjected to mechanical ventilation for less than 48 hours during their stay in the ICU between January 2021 and December 2023.
  • Patients who do not give their and, therefore, do not agree to participate in the interview.
  • Patients who have died during their stay in the ICU or in the period between 2021 and 2024.
  • Patients under 18 years of age.
  • Patients in whom it is not possible to collect all the information necessary to adequately assess post-ICU syndrome.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Observational model
Cohort
Time perspective
Cross-sectional
Enrollment
90 participants (estimated)
Patient registry
No

Groups and cohorts

  • Patients suffering from post-intensive care syndrome

    Patients suffering from at least one symptom of post-intensive care syndrome

    Diagnostic Test: Questionnaire and Physical Exam · Diagnostic Test: EuroQol 5-Dimension 3-Level · Diagnostic Test: EuroQol Visual Analogue Scale (EQ-VAS)

  • Patients not suffering from post-intensive care syndrome

    Patients without any symptom of post-intensive care syndrome

    Diagnostic Test: Questionnaire and Physical Exam · Diagnostic Test: EuroQol 5-Dimension 3-Level · Diagnostic Test: EuroQol Visual Analogue Scale (EQ-VAS)

Interventions

  • Diagnostic testQuestionnaire and Physical Exam

    Patients will be interviewed about the current suffering of post-intensive care symptoms

  • Diagnostic testEuroQol 5-Dimension 3-Level

    to assess health-related quality of life, focusing on the assessment of five key dimensions: mobility, self-care, daily activities, pain/discomfort and anxiety/depression.

  • Diagnostic testEuroQol Visual Analogue Scale (EQ-VAS)

    records the patient's self-rated health on a vertical visual analogue scale where endpoints are labelled: 0 "best imaginable health" - 100 "worst imaginable health"

06

What researchers measure

Primary outcomes

  1. Post-Intensive Care Unit Symptoms

    Rate of patients currently suffering of post-intensive care symptoms

    Time frame: More than 1 year after intensive care unit discharge

Secondary outcomes

  1. Quality of life assessment

    patient's self-rated health on a vertical visual analogue scale where endpoints are labelled: 0 "best imaginable health" - 100 "worst imaginable health"

    Time frame: More than 1 year after intensive care unit discharge

07

Study locations

1 site
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Start is estimated for Oct 2025; primary completion for Dec 2025, 2 months later.

How these figures are worked out, and which studies are left out of them.

Registered
Feb 26, 2025
First posted
Mar 4, 2025
StartEst.
Oct 1, 2025
Primary completionEst.
Dec 31, 2025
CompletionEst.
Jan 30, 2026
Last update
Sep 8, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Sep 8, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06857513
Lead sponsor
Hospital Universitario de Gran Canaria Doctor Negrín
Responsible party
Ángel Becerra-Bolaños, MD PhD (Principal Investigator, Hospital Universitario de Gran Canaria Doctor Negrín) — Principal investigator
First posted
Mar 4, 2025
Start date
Oct 1, 2025 (estimated)
Primary completion
Dec 31, 2025 (estimated)
Completion
Jan 30, 2026 (estimated)
Last update
Sep 8, 2025

Study contacts

Ángel Becerra Bolaños, MD PhD
Contact
angbecbol@gmail.com
+34676229025
Aurelio Rodríguez-Pérez, MD PhD
Contact
arodperp@gobiernodecanarias.org

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Sep 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion